Antibiotics, peptidoglycan synthesis and genomics: The chlamydial anomaly revisited

Microbiology

Volumn 144, Issue 10, 1998, Pages 2673-2678

  Chopra, Ian ^a   Storey, Christopher ^a   Falla, Timothy J ^a   Pearce, John H ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Antibiotics; Chlamydia; Genomics; Peptidoglycan

Indexed keywords

ANTIBIOTIC AGENT; PEPTIDOGLYCAN;

BACTERIAL GENETICS; BACTERIAL METABOLISM; CHLAMYDIA; GENOME; NONHUMAN; PRIORITY JOURNAL; REVIEW;

BACTERIA (MICROORGANISMS); CHLAMYDIA;

EID: 0031734732     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/00221287-144-10-2673     Document Type: Review

References (40)

1. Alary, M., Joly, J. R., Moutquin, J.-M. & 9 other authors (1994). Randomised comparison of amoxycillin and erythromycin in treatment of genital chlamydial infection in pregnancy. Lancet 344, 1461-1465.
2. Baltz, R. H., Morris, F. H., Matsushima, P. & 13 other authors (1998). DNA sequence sampling of the Streptococcus pneumoniae genome to identify novel targets for antibiotic development. Microb Drug Resist 4, 1-9.
3. Barbour, A. G., Amano, K.-I., Hackstadt, T., Perry, L. & Caldwell, H. D. (1982). Chlamydia trachomatis has penicillin-binding proteins but not detectable muramic acid. J Bacteriol 151, 420-428.
4. Bender, R. A. (1996). Variations on a theme by Escherichia. In Escherichia coli and Salmonella : Cellular and Molecular Biology, 2nd edn, pp. 4-9. Edited by F. C. Neidhardt and others. Washington, DC: American Society for Microbiology.
5. Chen, R. & Henning, U. (1987). Nucleotide sequence of the gene for the peptidoglycan-associated lipoprotein of Escherichia coli K12. Eur J Biochem 163, 73-77.
6. Everett, K. D. E. & Hatch, T. P. (1995). Architecture of the cell envelope of Chlamydia psittaci 6BC. J Bacteriol 177, 877-882.
7. Evers, D., Weckesser, J. & Jurgens, U. J. (1986). Chemical analyses on cell envelope polymers of the halophilic, phototrophic Rhodospirillum salexigens. Arch Microbiol 145, 254-258.
8. Fox, A., Rogers, J. C, Gilbart, J., Morgan, S., Davis, C. H., Knight, S. & Wyrick, P. B. (1990). Muramic acid is not detectable in Chlamydia psittaci or Chlamydia trachomatis by gas chromatography-mass spectrometry. Infect Immun 58, 835-837.
9. Garrett, A. J., Harrison, M. J. & Manire, G. P. (1974). A search for the bacterial mucopeptide component, muramic acid, in Chlamydia. J Gen Microbiol 80, 315-318.
10. Gump, D. W. (1996). Antimicrobial susceptibility testing for some atypical microorganisms: chlamydiae, mycoplasmas, rickettsia and spirochetes. In Antibiotics in Laboratory Medicine, 4th edn, pp. 212-229. Edited by V. Lorian. Baltimore: Williams & Wilkins.
11. Hatch, T. P. (1996). Disulfide cross-linked envelope proteins: the functional equivalent of peptidoglycan in Chlamydiae? J Bacteriol 178, 1-5.
12. van Heijenoort, J. (1996). Murein synthesis. In Escherichia coli and Salmonella: Cellular and Molecular Biology, 2nd edn, pp. 1615-1626. Edited by F. C. Neidhardt and others. Washington, DC: American Society for Microbiology.
13. Holtje, J.-V. & Tuomanen, E. I. (1991). The murein hydrolases of Escherichia coli, properties, functions and impact on the course of infections in vivo. J Gen Microbiol 137, 441-454.
14. How, S. J., Hobson, D. & Hart, C. A. (1984). Studies in vitro of the nature and synthesis of the cell wall of Chlamydia trachomatis. Curr Microbiol 10, 269-274.
15. Jenkin, H. M. (1960). Preparation and properties of cell walls of the agent of meningopneumonitis. J Bacterial 80, 639-647.
16. Jensen, R. A. (1996). Evolution of metabolic pathways in enteric bacteria. In Escherichia coli and Salmonella: Cellular and Molecular Biology, 2nd edn, pp. 2649-2662. Edited by F. C. Neidhardt and others. Washington, DC: American Society for Microbiology.
17. Kreil, G. (1997). D-Amino acids in animal peptides. Annu Rev Biochem 66, 337-345.
18. Kuo, C. C. & Grayston, J. T. (1988). In vitro drug susceptibility of Chlamydia sp. strain TWAR. Antimicrob Agents Chemother 32, 257-258.
19. Lutkenhaus, J. & Mukherjee, A. (1996). Cell division. In Escherichia coli and Salmonella : Cellular and Molecular Biology, 2nd edn, pp. 1615-1626. Edited by F. C. Neidhardt and others. Washington, DC: American Society for Microbiology.
20. +-dependent transport system from a marine bacterium. J Bacteriol 165, 825-830.
21. +-linked gene from the marine bacterium Alteromonas haloplanktis which functionally complements the dagA gene of Escherichia coli. Mol Microbiol 6, 2673-2681.
22. Manire, G. P. & Tamura, A. (1967). Preparation and chemical composition of the cell walls of mature infectious dense forms of meningopneumonitis organisms. J Bacteriol 94, 1178-1183.
23. Massova, I. & Mobashery, S. (1998). Kinship and diversification of bacterial penicillin-binding proteins and β-lactamases. Antimicrob Agents Chemother 42, 1-17.
24. Matsumoto, A. & Manire, G. P. (1970). Electron microscopic observations on the effects of penicillin on the morphology of Chlamydia psittaci. J Bacteriol 101, 278-285.
25. Moulder, J. W. (1991). Interaction of chlamydiae and host cells in vitro. Microbiol Rev 55, 143-190.
26. Moulder, J. W. (1993). Why is Chlamydia sensitive to penicillin in the absence of peptidoglycan? Infect Agents Dis 2, 87-99.
27. Perkins, H. R. & Allison, A. C. (1963). Cell-wall constituents of rickettsiae and psittacosis-lymphogranuloma organisms. J Gen Microbiol 30, 469-480.
28. Pollack, J. D. (1997). Mycoplasma genes: a case for reflective annotation. Trends Microbiol 5, 413-419.
29. Robbins, J. C. & Oxender, D. L. (1973). Transport systems for alanine, serine and glycine in Escherichia coli K-12. J Bacteriol 116, 12-18.
30. Roberts, M. C. (1992). Antibiotic resistance. In Mycoplasmas: Molecular Biology and Pathogenesis, pp. 513-523. Edited by R. N. McElhaney, L. R. Finch & J. B. Baseman. Washington, DC: American Society for Microbiology.
31. Rogers, H. J., Perkins, H. R. & Ward, J. B. (1980). Microbial Cell Walls and Membranes. London: Chapman & Hall.
32. Russell, A. D. & Chopra, I. (1996). Understanding Antibacterial Action and Resistance, 2nd edn. London: Ellis Horwood.
33. Schachter, J. (1992). Chlamydia. In Infectious Diseases, pp. 1633-1641. Edited by S. L. Gorbach, J. G. Barrlett & N. R. Blacklow. Philadelphia: W. B. Saunders.
34. Schleifer, K. H. & Kandler, O. (1972). Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol Rev 36, 407-477.
35. Shah, H. N., Gharbia, S. E. & Collins, M. D. (1997). The Gram stain: a declining synapomorphy in an emerging evolutionary tree. Rev Med Microbiol 8, 103-110.
36. Stackebrandt, E., Ludwig, W., Schubert, W., Klink, F., Schlesner, H., Roggentin, T. & Hirsch, P. (1984). Molecular genetic evidence for early evolutionary origin of budding peptidoglycan-less eubacteria. Nature 307, 735-737.
37. Stephens, R. S., Kalman, S., Fenner, C. & Davis, R. (1998). Chlamydia Genome Project. University of California at Berkeley and Stanford University. http://violet. berkeley.edu:4231/.
38. Tamura, A. & Manrie, G. P. (1968). Effect of penicillin on the multiplication of meningopneumonitis organisms (Chlamydia psittaci). J Bacteriol 96, 875-880.
39. Toomey, K. E. & Barnes, R. C. (1990). Treatment of Chlamydia trachomatis genital infection. Rev Infect Dis 12, S645-S655.
40. Wachi, M. & Matsuhashi, M. (1989). Negative control of cell division by mreB, a gene that functions in determining the rod shape of Escherichia coli cells. J Bacteriol 171, 3123-3127.